PRNewswire · Jun 2026
Scispot announced an $8M Series A led by Avenue Growth Partners, with proceeds aimed at scaling product, engineering, AI, implementation, and customer success.
Company research
Public company, workplace, funding, and market signals
Overview
AI-native lab operating system for biotech and diagnostics teams that unifies experiment planning, execution, documentation, inventory, sample tracking, and compliance.
Primary product
Scispot LabOS (with modular apps such as Labsheets, Labflows, Labspaces, GLUE, and Scibot)
Founded
2020
Headquarters
Kitchener-Waterloo, Ontario, Canada
Team size
20-34 employees
Work style
Flexible
Industry
Biotechnology Research
Sub-industry
Lab informatics / lab operating system / LIMS-ELN software
Offices
Kitchener
Seattle
London
San Francisco
Montreal
Business model
SaaS subscription
per-user pricing
usage-based tiers for automation and data volume
implementation and onboarding services
Funding
Stage
Series A
Total raised
$10.1M
Latest round
Series A · Jun 2026
Latest amount
$8M
People & investors
Leadership
Founder & CEO
Co-Founder, CPO & President
Director of Business Development
Head of Artificial Intelligence
Head of Innovation
Director of Customer Strategy
Business Development Director
Fractional CFO
Founding GTM Automation Engineer
Work & culture
Mission-driven, fast-paced, collaborative, customer-centric, transparent, and impact-oriented; blends biotech/science with software/automation.
Work style
Flexible
Compensation
Competitive salary or pay based on skills, experience, and location; stock options are common, and some roles include performance-based incentives.
Benefits
stock options
health benefits
full healthcare coverage
flexible hours
remote work flexibility
hybrid work for some roles
budget for training
mentorship from experienced AI and biotech experts
career advancement opportunities
access to Communitech and Velocity programs
Product & market
Pricing
Annual subscription with tiered plans (Essential, Professional, Enterprise); pricing scales by user count, integrations, automation/data volume, and compliance scope, with implementation fees and add-ons.
Differentiators
- —AI-native lab operating layer / LabOS
- —combines ELN, LIMS, SDMS, LIS, QMS, and workflow automation
- —GLUE integration engine for instruments, apps, and databases
- —no-code plus API/CLI configuration
- —sample-centric traceability and audit-ready controls
- —knowledge graph and RAG-backed retrieval for SOPs and records
- —natural-language analytics and AI lab assistant (Scibot)
- —7,000+ app integrations and 250+ instrument connections
- —built-in compliance support for 21 CFR Part 11, ISO 15189, and EU Annex 11
- —designed to work with existing stacks instead of ripping and replacing them
Technology
Python
Java
React
TypeScript
PostgreSQL
MongoDB
Redis
RabbitMQ
Kubernetes
Docker
AWS Lambda
Terraform
Datadog
Elasticsearch
OpenAI
GraphQL
Zapier
HubSpot
Salesforce
Sentry
Customers
Arrakis Therapeutics
biotech startups
biopharma
diagnostics labs
clinical genomics labs
molecular pathology labs
infectious disease testing labs
CRO/CDMO labs
biobanking labs
testing labs
Competitors
Benchling
Dotmatics
LabWare
LabVantage
Sapio Sciences
L7 Informatics
Labguru
Collaborative Drug Discovery
Uncountable
STARLIMS
Scale & contact
Estimated revenue
about $2.8M in 2024 (third-party estimate)
Estimated monthly visits
36.6K
Traffic estimate as of Apr 2026
Latest news
PRWeb · Apr 2026
Introduced an agent-to-agent connection layer and MCP/A2A capabilities for governed AI actions across lab workflows.
PRWeb · Apr 2026
Launched a compliance workspace for GLP, CAP, CLIA, and 21 CFR Part 11 labs to keep validation and inspection evidence inside the platform.
Scispot Blog · Oct 2025
Detailed a pathology workflow vision centered on Labflows, knowledge graphs, QC gates, e-signatures, and chain-of-custody traceability.
PRWeb · Sep 2024
Launched Labflows for sample-centric workflows in molecular diagnostics, genetic testing, molecular pathology, and related regulated labs.
Jobs and careers at Scispot
0 jobs at Scispot
No open positions
Check back later for new openings